-
1
-
-
9144241697
-
In vivo role of myeloperoxidase for the host defense
-
Aratani Y., Kura F., Watanabe H., et al. In vivo role of myeloperoxidase for the host defense. Jpn J Infect Dis 57 (2004) S15
-
(2004)
Jpn J Infect Dis
, vol.57
-
-
Aratani, Y.1
Kura, F.2
Watanabe, H.3
-
2
-
-
0042626223
-
Emerging role of myeloperoxidase and oxidant stress markers in cardiovascular risk assessment
-
Brennan M.-L., and Hazen S.L. Emerging role of myeloperoxidase and oxidant stress markers in cardiovascular risk assessment. Curr Opin Lipidol 14 (2003) 353-359
-
(2003)
Curr Opin Lipidol
, vol.14
, pp. 353-359
-
-
Brennan, M.-L.1
Hazen, S.L.2
-
3
-
-
0037195783
-
Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation
-
Zhang R., Brennan M.L., Shen Z., et al. Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation. J Biol Chem 277 (2002) 46116-46122
-
(2002)
J Biol Chem
, vol.277
, pp. 46116-46122
-
-
Zhang, R.1
Brennan, M.L.2
Shen, Z.3
-
4
-
-
0032701646
-
Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro
-
Podrez E.A., Schmidt D., Hoff H.F., et al. Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. J Clin Invest 103 (1999) 1547-1560
-
(1999)
J Clin Invest
, vol.103
, pp. 1547-1560
-
-
Podrez, E.A.1
Schmidt, D.2
Hoff, H.F.3
-
5
-
-
0035824162
-
Association between myeloperoxidase levels and risk of coronary artery disease
-
Zhang R., Brennan M.L., Fu X., et al. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 286 (2001) 2136-2142
-
(2001)
JAMA
, vol.286
, pp. 2136-2142
-
-
Zhang, R.1
Brennan, M.L.2
Fu, X.3
-
6
-
-
0142089171
-
Prognostic value of myeloperoxidase in patients with chest pain
-
Brennan M.-L., Penn M.S., Lente F.V., et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 349 (2003) 1595-1604
-
(2003)
N Engl J Med
, vol.349
, pp. 1595-1604
-
-
Brennan, M.-L.1
Penn, M.S.2
Lente, F.V.3
-
7
-
-
0141727730
-
Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes
-
Baldus S., Heeschen C., Meinertz T., et al. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 108 (2003) 1440-1445
-
(2003)
Circulation
, vol.108
, pp. 1440-1445
-
-
Baldus, S.1
Heeschen, C.2
Meinertz, T.3
-
8
-
-
33644667767
-
Linking inflammation and atherogenesis: Soluble markers identified for the detection of risk factors and for early risk assessment
-
Wu J.T., and Wu L.L. Linking inflammation and atherogenesis: Soluble markers identified for the detection of risk factors and for early risk assessment. Clin Chim Acta 366 (2006) 74-80
-
(2006)
Clin Chim Acta
, vol.366
, pp. 74-80
-
-
Wu, J.T.1
Wu, L.L.2
-
9
-
-
23844510478
-
Association of soluble markers with various stages and major events of atherosclerosis
-
Wu J.T., and Wu L.L. Association of soluble markers with various stages and major events of atherosclerosis. Ann Clin Lab Sci 35 (2005) 240-250
-
(2005)
Ann Clin Lab Sci
, vol.35
, pp. 240-250
-
-
Wu, J.T.1
Wu, L.L.2
-
10
-
-
29144511607
-
MAPK signalling pathways as molecular targets for anti-inflammatory therapy-from molecular mechanisms to therapeutic benefits
-
Kaminska B. MAPK signalling pathways as molecular targets for anti-inflammatory therapy-from molecular mechanisms to therapeutic benefits. Biochim Biophys Acta 1754 (2005) 253-262
-
(2005)
Biochim Biophys Acta
, vol.1754
, pp. 253-262
-
-
Kaminska, B.1
-
11
-
-
28244488706
-
Inflammation-activated protein kinases as targets for drug development
-
Karin M. Inflammation-activated protein kinases as targets for drug development. Proc Am Thorac Soc 2 (2005) 386-390
-
(2005)
Proc Am Thorac Soc
, vol.2
, pp. 386-390
-
-
Karin, M.1
-
12
-
-
27944505915
-
PPARs in diseases: control mechanisms of inflammation
-
Kostadinova R., Wahli W., and Michalik L. PPARs in diseases: control mechanisms of inflammation. Curr Med Chem 12 (2005) 2995-3009
-
(2005)
Curr Med Chem
, vol.12
, pp. 2995-3009
-
-
Kostadinova, R.1
Wahli, W.2
Michalik, L.3
-
13
-
-
0028076845
-
Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for the initiation of lipid peroxidation in low density lipoprotein
-
Savenkova M., Mueller D.M., and Heinecke J.W. Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for the initiation of lipid peroxidation in low density lipoprotein. J Biol Chem 269 (1994) 20394-20400
-
(1994)
J Biol Chem
, vol.269
, pp. 20394-20400
-
-
Savenkova, M.1
Mueller, D.M.2
Heinecke, J.W.3
-
14
-
-
0034659148
-
The oxidative modification hypothesis of atherogenesis: an overview
-
Chisolm G.M., and Steinberg D. The oxidative modification hypothesis of atherogenesis: an overview. Free Radic Biol Med 28 (2000) 1815-1826
-
(2000)
Free Radic Biol Med
, vol.28
, pp. 1815-1826
-
-
Chisolm, G.M.1
Steinberg, D.2
-
15
-
-
0032739169
-
Formation of nitric oxide-derived oxidants by myeloperoxidase in monocytes: pathways for monocyte-mediated protein nitration and lipid peroxidation In vivo
-
Hazen S.L., Zhang R., Shen Z., et al. Formation of nitric oxide-derived oxidants by myeloperoxidase in monocytes: pathways for monocyte-mediated protein nitration and lipid peroxidation In vivo. Circ Res 85 (1999) 950-958
-
(1999)
Circ Res
, vol.85
, pp. 950-958
-
-
Hazen, S.L.1
Zhang, R.2
Shen, Z.3
-
16
-
-
0034659164
-
Myeloperoxidase-generated oxidants and atherosclerosis
-
Podrez E.A., Abu-Soud H.M., and Hazen S.L. Myeloperoxidase-generated oxidants and atherosclerosis. Free Radic Biol Med 28 (2000) 1717-1725
-
(2000)
Free Radic Biol Med
, vol.28
, pp. 1717-1725
-
-
Podrez, E.A.1
Abu-Soud, H.M.2
Hazen, S.L.3
-
17
-
-
0033593070
-
Leukocytes utilize myeloperoxidase-generated nitrating intermediates as physiological catalysts for the generation of biologically active oxidized lipids and sterols in serum
-
Schmitt D., Shen Z., Zhang R., et al. Leukocytes utilize myeloperoxidase-generated nitrating intermediates as physiological catalysts for the generation of biologically active oxidized lipids and sterols in serum. Biochemistry 38 (1999) 16904-16915
-
(1999)
Biochemistry
, vol.38
, pp. 16904-16915
-
-
Schmitt, D.1
Shen, Z.2
Zhang, R.3
|